Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Labour has the UK’s wealthier over-65s in its sights
    • UK universities regulator plans for looming insolvencies
    • Fresh violence flares after dozens of rioters arrested across England
    • Asset managers fret over lost gains as investor cash piles up on sidelines
    • The power of choosing your words wisely
  • US
    Sections
    • US Home
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
    Most Read
    • Asset managers fret over lost gains as investor cash piles up on sidelines
    • The power of choosing your words wisely
    • Blessed are the bean counters — except when it comes to growth
    • Democratic party’s ‘Trump is weird’ strategy rattles Republicans
    • The battle over who makes the rules for US companies
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Blessed are the bean counters — except when it comes to growth
    • Widespread boycotts in Muslim countries hammer western brands
    • Novo Nordisk boosts research as rivals challenge weight-loss leader
    • The battle over who makes the rules for US companies
    • Why pension funds should not be patriots
  • Tech
    Sections
    • Tech Home
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
    Most Read
    • Lloyds hires Amazon Web Services executive as its new AI chief
    • A rollercoaster earnings season for tech stocks
    • Brain implant made from graphene is set to begin UK clinical trial
    • Elliott says Nvidia is in a ‘bubble’ and AI is ‘overhyped’
    • Bolt promises benefits to gig workers ahead of court battle with union
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Global shares tumble as US recession fears rattle markets
    • Asset managers fret over lost gains as investor cash piles up on sidelines
    • Everyone calm down
    • Rio Tinto-backed start-up seeks funds for lithium breakthrough to cut reliance on China
    • Global stock sell-off deepens after disappointing US jobs data
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • The power of choosing your words wisely
    • Blessed are the bean counters — except when it comes to growth
    • The volatile far right on UK streets is becoming more difficult to label
    • Why pension funds should not be patriots
    • What might a Harris foreign policy look like?
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Tesla attempt to save Elon Musk’s $56bn pay package gets sceptical reception
    • Cities on screen: Choose Edinburgh
    • Bolt promises benefits to gig workers ahead of court battle with union
    • ‘Gone are the days of taking a phone call in the open’: why office pods are everywhere
    • How Roger Federer rode the ‘beautiful wave’ of tennis for 24 years
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • What and how to read
    • One of Scandinavia’s buzziest fashion brands is ready to scale
    • Photobombing de Gaulle: how a forgotten picture rewrites the history of WWII
    • Could music win it for Kamala Harris?
    • The True Story of the Fake Zombies podcast review — how a band came back to life, twice over
  • HTSI
  1. Companies
  2. Health
  • Healthcare
  • Pharmaceuticals
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Health

  • Monday, 5 August, 2024
    Novo Nordisk AS
    Novo Nordisk boosts research as rivals challenge weight-loss leader

    Maker of Wegovy and Ozempic has 45,000 patients in clinical trials as it seeks to stave off threats from Eli Lilly and Roche

    A scientist holds a vial
  • Saturday, 3 August, 2024
    Neurotechnology
    Brain implant made from graphene is set to begin UK clinical trial

    Patients in Manchester will take part in first study using ‘wonder material’ that was discovered in the city

    An image of an InBrain cortical interface
  • Friday, 2 August, 2024
    The Big Read
    How medical research is failing women

    For years, the process for developing and testing new drugs has focused disproportionately on male bodies — to the detriment of female patients

  • Friday, 2 August, 2024
    Data PointsJohn Burn-Murdoch
    Are the super shoes used in Olympic races distorting results?

    New technology is creating an uneven playing field in athletics

    A bright neon green Nike ZoomX running shoe with a vibrant multicolored sole, featuring shades of yellow, orange, and blue, is displayed against a beige background. A red zigzag line and an upward-pointing arrow are overlaid on the background
  • Thursday, 1 August, 2024
    UK labour disputes
    GPs in England to cap appointments in latest industrial action

    Family doctors voted for move in dispute over pay

    Consultants and junior doctors on the picket line in London last year
  • Thursday, 1 August, 2024
    Women's health
    ADHD cases in women hit record level as TikTok videos raise awareness

    Huge rise in prescriptions for women aged 25 to 34 in England driven by social media highlighting symptoms

    Screengrabs from TikTok of videos about ADHD
  • Wednesday, 31 July, 2024
    Dementia
    High cholesterol critical factor in development of dementia, study finds

    Reducing 14 ‘modifiable’ risks can prevent or delay cognitive disorder, report says

    Doctor reviewing MRI scans
  • Wednesday, 31 July, 2024
    The best books of the week
    Well Beings — James Riley’s look back at the evolution of wellness experiments

    An engrossing and timely book, with some fantastically weird anecdotes, about how the wellness movement took root in the 1970s

    A black-and-white photo of a large group of people practising yoga in the sun, all of them in reverse tabletop position, straight arms, bent legs with chests thrust skyward
  • Tuesday, 30 July, 2024
    Anjana Ahuja
    Speedy sepsis test could save lives — but only if health systems can keep up

    The illness causes more deaths than strokes but a new time-saving technology may be able to help

    Andy Carter illustration of a hand holding a looking glass in the form of a ticking clock displaying germs in different colours
  • Tuesday, 30 July, 2024
    Digital health
    Fertility app Flo valuation reaches $1bn as women’s health market takes off

    Private equity firm General Atlantic backs start-up as it turns to ‘untapped’ market of those experiencing menopause

    Mobile phone being held, displaying Flo app
  • Tuesday, 30 July, 2024
    News in-depthUK society
    More women in England opt for private IVF treatments

    Academics and charities call for a national policy for providing fertility treatment on NHS

    A montage of a baby and a chart
  • Monday, 29 July, 2024
    Disease control and prevention
    NHS watchdog blocks AstraZeneca breast cancer drug

    Nice blames cost for not recommending Enhertu, which has helped patients in clinical trials live longer

    Women demonstrate outside Parliament
  • Monday, 29 July, 2024
    Roche Holding AG
    Roche to fast-track weight-loss pill to compete with rivals

    Swiss drugmaker unveils promising data for obesity drug

    Passers-by are silhouetted as they walk along the banks of river Rhine next to the Roche towers
  • Monday, 29 July, 2024
    ReviewArts
    Hysterical — search for an explanation behind a wave of teenage mental illness

    Dan Taberski looks at the events of 2011 in a New York town when a group of girls all came down with Tourette’s-like symptoms

    A group of female cheerleaders on a sports field wearing red outfits and carrying white pompoms seen from behind
  • Sunday, 28 July, 2024
    News in-depthMedical science
    The hunt for a rare nuclear isotope that could redefine cancer care

    Extreme shortages of actinium are holding up the promising field of radiopharmaceuticals

    President of Tuscany Eugenio Giani visits  the Monasterio Foundation in Pisa , which houses the the cyclotron of the Institute of Clinical Physiology of the National Research Council
  • Friday, 26 July, 2024
    Pharmaceuticals sector
    European Medicines Agency rejects breakthrough Alzheimer’s drug

    Eisai and Biogen face uphill battle to win EU approval for Leqembi after committee’s ruling

    Bottles and packages of the drug Leqembi
  • Friday, 26 July, 2024
    Gardens
    The secret Hong Kong garden that’s a portal to the past

    Chan Siun-kuen left rural China in the slipstream of the revolution for a rapidly urbanising Hong Kong. His herb garden restores a connection to forgotten traditions and the healing power of plants

    An entrance to a planting site at Lung Fu Shan Country Park, marked by a weathered wooden sign. The site is lush with various plants and trees, with a dirt path leading into the greenery
  • Thursday, 25 July, 2024
    Care Quality Commission
    NHS safety regulator found to have ‘significant internal failings’

    Care Quality Commission’s shortcomings are ‘hampering’ its ability to identify poor performance, says independent review

    Healthcare workers in a hospital
  • Thursday, 25 July, 2024
    Dementia
    Shingles vaccine ‘may prevent dementia’, research finds

    GSK’s Shingrix is latest drug to show potential for targeting previously untreatable brain disorders

    Shingrix shingles vaccine
  • Thursday, 25 July, 2024
    National Health Service
    NHS warns England has fewer than two days’ supply of vital O-negative blood

    Amber alert triggered as blood stocks fall to ‘unprecedentedly low levels’

    Mobile blood collection vehicles parked outside
  • Wednesday, 24 July, 2024
    FT SeriesDon’t miss – HTSI’s most popular stories
    The best e-bikes for every ride

    From cargo carriers to urban cruisers, these are the top performers in power-assisted pedalling

    Van Rysel Electrical Assistance Road Bike E-EDR AF Apex AXS 1x12, £2,300
  • Wednesday, 24 July, 2024
    National Health Service
    NHS prescriptions for Wegovy held back by lack of weight-loss clinics

    Long waiting list for drug because of shortage of specialist services could hit patients unable to pay privately

    Boxes of Wegovy
  • Wednesday, 24 July, 2024
    FT Globetrotter
    Running in Edinburgh: an insider’s guide to three top routes

    Where to take in the landmarks and lesser-known gems

    The writer jogging around Ross Fountain in Princes Street Gardens, Edinburgh, with Edinburgh Castle on the top of a rocky hill in the background
  • Tuesday, 23 July, 2024
    Israel-Hamas war
    WHO warns Gaza at ‘high risk’ of polio outbreak

    Health organisation says the risk of transmission is high because of ‘the very dire situation with water sanitation’

  • Tuesday, 23 July, 2024
    Pollution
    Risk of lead contamination in UK food chain should be assessed, says senior scientist

    Senior toxicologist warns about toxic metals leaking from disused mines, calls for urgent monitoring

    People dining out in London
Previous page You are on page 1 Next page

Most Read

  1. Are the super shoes used in Olympic races distorting results?
  2. Novo Nordisk boosts research as rivals challenge weight-loss leader
  3. Brain implant made from graphene is set to begin UK clinical trial
  4. How medical research is failing women
  5. High cholesterol critical factor in development of dementia, study finds

Join us at an FT Live event

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Explore all events

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Edition:International
UK
Subscribe for full access

Top sections

  • Home
  • World
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • US
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In